Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular

Raul Velez-Montoya1, Dulce Rascón-Vargas, William F Mieler

  • 1Retina Department, Associacition to prevent blindness in México IAP, México City, Mexico.

Journal of Ophthalmology
|August 14, 2010
PubMed

Insights

A rare eye infection, Streptococcus uberis endophthalmitis, occurred post-surgery. Treatment with intravitreal ampicillin sodium showed limited success, highlighting antibiotic resistance challenges in ocular infections.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Postoperative endophthalmitis is a severe intraocular infection following eye surgery.
  • Streptococcus uberis, typically associated with bovine mastitis, is an uncommon cause of human endophthalmitis.

Observation:

  • A 52-year-old diabetic patient developed severe pain and vision loss after vitrectomy.
  • The patient was diagnosed with postoperative endophthalmitis caused by a highly resistant strain of Streptococcus uberis.

Findings:

  • Standard intravitreal antibiotics were ineffective against the resistant Streptococcus uberis strain.
  • Treatment involved surgical intervention, anterior chamber washout, and intravitreal ampicillin sodium with silicon oil tamponade.
  • While the eye was anatomically stabilized, functional vision recovery was not achieved.

Implications:

  • This case highlights the potential for unusual pathogens like Streptococcus uberis to cause severe ocular infections.
  • The unique resistance mechanisms of this pathogen pose treatment challenges.
  • Intravitreal ampicillin sodium is a potential treatment, but its efficacy and toxicity require further investigation.